Details
Product Name in the RMS: Mirzasna 15 mg
MR Number: NL/H/1087/001
Date of outcome: 21.11.2007
| Type of application | |
|---|---|
|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Initial Application Generic Chemical Substance Prescription Only |
| Active Substances |
mirtazapine 15 mg |
| Form | Orodispersible tablet |
| MA Holder in the RMS |
Krka d.d. Novo MEsto Šmarješka cesta 6 8501 Novo mesto Slovenia |
| RMS | Netherlands |
| Date of last change | 14.09.2012 |
| ATC-Code |
N06AX11 Mirtazapine |
| CMS Country | Domestic Product Name |
|---|---|
| Bulgaria | Mirzaten Q TAB |
| Czech Republic | Mirzaten Oro Tab 15 mg orodispersible tablets |
| Denmark | 41901 |
| Estonia | |
| Germany | Mirzaten 15 mg Schmelztabletten |
| Norway | |
| Poland | Mirzaten Q-Tab 15 mg tabletki ulegające rozpadowi w jamie ustnej |
| Romania | Mirzaten Q-Tab 15 mg comprimate orodispersabile |
| Slovak Republic | |
| Sweden | Mirtin |
| United Kingdom |
| Documents | |
|---|---|
| PAR: | http://db.cbg-meb.nl/mri/par/nlh-1087-001-002-003.pdf (26.04.2010) |
| Finalised Product Information: | http://mri.medagencies.org/download/NL_H_1087_001_FinalPI.pdf (17.08.2012) |


